Unknown

Dataset Information

Supportive evidence for reduced expression of GNB1L in schizophrenia.


ABSTRACT:

Background

Chromosome 22q11 deletion syndrome (22q11DS) increases the risk of development of schizophrenia more than 10 times compared with that of the general population, indicating that haploinsufficiency of a subset of the more than 20 genes contained in the 22q11DS region could increase the risk of schizophrenia. In the present study, we screened for genes located in the 22q11DS region that are expressed at lower levels in postmortem prefrontal cortex of patients with schizophrenia than in those of controls.

Methods

Gene expression was screened by Illumina Human-6 Expression BeadChip arrays and confirmed by real-time reverse transcription-polymerase chain reaction assays and Western blot analysis.

Results

Expression of GNB1L was lower in patients with schizophreni

SUBMITTER: Ishiguro H 

PROVIDER: S-EPMC2894596 | biostudies-literature | 2010 Jul

REPOSITORIES: biostudies-literature